Paid Clinical Trials Baton Rouge

Discover 232 paid clinical trials in Baton Rouge, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 232

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Baton Rouge, New Orleans, Alexandria, Birminghamshow 78 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

AngelMed Guardian® System PMA Post Approval Study

Recruiting

Sponsor:

Angel Medical Systems

Location:

Hammond, Covington, Mandeville, Fort Worthshow 11 more

Code:

NCT05412927

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

PMA P150009 AngelMed Guardian® System

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Baton Rouge, Kenner, Metairie, New Orleansshow 350 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

Lymphedema Treatment for Blunt Facial Trauma

Recruiting

Sponsor:

Our Lady of the Lake Hospital

Location:

Baton Rouge

Code:

NCT02977182

Conditions

Post-traumatic Facial Edema

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Complete Decongestive Therapy (CDT)

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria

Recruiting

PHASE2

Sponsor:

Evommune, Inc.

Location:

Baton Rouge, Birmingham, Pflugerville, Oklahoma Cityshow 12 more

Code:

NCT06603220

Conditions

Chronic Inducible Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Oral EVO756

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab

Recruiting

PHASE1

Sponsor:

AbbVie

Location:

Henderson, Houston, San Antonio, Huntersvilleshow 12 more

Code:

NCT05029882

Conditions

Non-Small Cell Lung Cancer

Advanced Solid Tumors

Gastroesophageal Adenocarcinoma

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-400

Trifluridine/Tipiracil

Bevacizumab

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Recruiting

PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Hammond, New Orleans, Bogalusa, Alexandriashow 157 more

Code:

NCT05636176

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab

Placebo

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Recruiting

Sponsor:

Medtronic

Location:

Baton Rouge, Hattiesburg, Shreveport, Houstonshow 106 more

Code:

NCT00271180

Conditions

Arrhythmia

Bradycardia

Heart Failure

Sinus Tachycardia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Device

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Lafayette, New Orleans, Mobile, Tylershow 25 more

Code:

NCT05692180

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Benralizumab

Placebo

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Baton Rouge, Hammond, Thibodaux, Lafayetteshow 944 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression